Global Lung Cancer Diagnostic Tests Market Research Report 2025(Status and Outlook)
Report Overview
The global Lung Cancer Diagnostic Tests market size was estimated at USD 3215.4 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Lung Cancer Diagnostic Tests market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Lung Cancer Diagnostic Tests market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Lung Cancer Diagnostic Tests market
Global Lung Cancer Diagnostic Tests Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Advpharma Inc
AIT Austrian Institute of Technology GmbH
Courtagen Life Sciences Inc
DiagnoCure Inc. (Inactive)
BioMark Diagnostics Inc.
BioMarker Strategies LLC
Emory University
Epigenomics AG
GlycoZym
HalioDx SAS
Louisville BioscienceInc.
Mayo Clinic US
Market Segmentation (by Type)
Immunoassays
Flow Cytometry
Rapid Tests
Molecular Assays
Tissue Arrays
Circulating Tumor Cells
Pharmacodiagnostics
Biomarkers
Other Diagnostics Methods
Market Segmentation (by Application)
Precision Medicine
Personalized Medicine
Cancer Monitoring
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Lung Cancer Diagnostic Tests Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Lung Cancer Diagnostic Tests, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Lung Cancer Diagnostic Tests market size was estimated at USD 3215.4 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Lung Cancer Diagnostic Tests market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Lung Cancer Diagnostic Tests market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Lung Cancer Diagnostic Tests market
Global Lung Cancer Diagnostic Tests Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Advpharma Inc
AIT Austrian Institute of Technology GmbH
Courtagen Life Sciences Inc
DiagnoCure Inc. (Inactive)
BioMark Diagnostics Inc.
BioMarker Strategies LLC
Emory University
Epigenomics AG
GlycoZym
HalioDx SAS
Louisville BioscienceInc.
Mayo Clinic US
Market Segmentation (by Type)
Immunoassays
Flow Cytometry
Rapid Tests
Molecular Assays
Tissue Arrays
Circulating Tumor Cells
Pharmacodiagnostics
Biomarkers
Other Diagnostics Methods
Market Segmentation (by Application)
Precision Medicine
Personalized Medicine
Cancer Monitoring
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Lung Cancer Diagnostic Tests Market
- Overview of the regional outlook of the Lung Cancer Diagnostic Tests Market.
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Lung Cancer Diagnostic Tests Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Lung Cancer Diagnostic Tests, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Lung Cancer Diagnostic Tests
1.2 Key Market Segments
1.2.1 Lung Cancer Diagnostic Tests Segment by Type
1.2.2 Lung Cancer Diagnostic Tests Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LUNG CANCER DIAGNOSTIC TESTS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Lung Cancer Diagnostic Tests Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Lung Cancer Diagnostic Tests Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LUNG CANCER DIAGNOSTIC TESTS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Lung Cancer Diagnostic Tests Product Life Cycle
3.3 Global Lung Cancer Diagnostic Tests Sales by Manufacturers (2020-2025)
3.4 Global Lung Cancer Diagnostic Tests Revenue Market Share by Manufacturers (2020-2025)
3.5 Lung Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Lung Cancer Diagnostic Tests Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Lung Cancer Diagnostic Tests Market Competitive Situation and Trends
3.8.1 Lung Cancer Diagnostic Tests Market Concentration Rate
3.8.2 Global 5 and 10 Largest Lung Cancer Diagnostic Tests Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 LUNG CANCER DIAGNOSTIC TESTS INDUSTRY CHAIN ANALYSIS
4.1 Lung Cancer Diagnostic Tests Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LUNG CANCER DIAGNOSTIC TESTS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Lung Cancer Diagnostic Tests Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Lung Cancer Diagnostic Tests Market
5.7 ESG Ratings of Leading Companies
6 LUNG CANCER DIAGNOSTIC TESTS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Lung Cancer Diagnostic Tests Sales Market Share by Type (2020-2025)
6.3 Global Lung Cancer Diagnostic Tests Market Size Market Share by Type (2020-2025)
6.4 Global Lung Cancer Diagnostic Tests Price by Type (2020-2025)
7 LUNG CANCER DIAGNOSTIC TESTS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Lung Cancer Diagnostic Tests Market Sales by Application (2020-2025)
7.3 Global Lung Cancer Diagnostic Tests Market Size (M USD) by Application (2020-2025)
7.4 Global Lung Cancer Diagnostic Tests Sales Growth Rate by Application (2020-2025)
8 LUNG CANCER DIAGNOSTIC TESTS MARKET SALES BY REGION
8.1 Global Lung Cancer Diagnostic Tests Sales by Region
8.1.1 Global Lung Cancer Diagnostic Tests Sales by Region
8.1.2 Global Lung Cancer Diagnostic Tests Sales Market Share by Region
8.2 Global Lung Cancer Diagnostic Tests Market Size by Region
8.2.1 Global Lung Cancer Diagnostic Tests Market Size by Region
8.2.2 Global Lung Cancer Diagnostic Tests Market Size Market Share by Region
8.3 North America
8.3.1 North America Lung Cancer Diagnostic Tests Sales by Country
8.3.2 North America Lung Cancer Diagnostic Tests Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Lung Cancer Diagnostic Tests Sales by Country
8.4.2 Europe Lung Cancer Diagnostic Tests Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Lung Cancer Diagnostic Tests Sales by Region
8.5.2 Asia Pacific Lung Cancer Diagnostic Tests Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Lung Cancer Diagnostic Tests Sales by Country
8.6.2 South America Lung Cancer Diagnostic Tests Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Lung Cancer Diagnostic Tests Sales by Region
8.7.2 Middle East and Africa Lung Cancer Diagnostic Tests Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 LUNG CANCER DIAGNOSTIC TESTS MARKET PRODUCTION BY REGION
9.1 Global Production of Lung Cancer Diagnostic Tests by Region(2020-2025)
9.2 Global Lung Cancer Diagnostic Tests Revenue Market Share by Region (2020-2025)
9.3 Global Lung Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Lung Cancer Diagnostic Tests Production
9.4.1 North America Lung Cancer Diagnostic Tests Production Growth Rate (2020-2025)
9.4.2 North America Lung Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Lung Cancer Diagnostic Tests Production
9.5.1 Europe Lung Cancer Diagnostic Tests Production Growth Rate (2020-2025)
9.5.2 Europe Lung Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Lung Cancer Diagnostic Tests Production (2020-2025)
9.6.1 Japan Lung Cancer Diagnostic Tests Production Growth Rate (2020-2025)
9.6.2 Japan Lung Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Lung Cancer Diagnostic Tests Production (2020-2025)
9.7.1 China Lung Cancer Diagnostic Tests Production Growth Rate (2020-2025)
9.7.2 China Lung Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Advpharma Inc
10.1.1 Advpharma Inc Basic Information
10.1.2 Advpharma Inc Lung Cancer Diagnostic Tests Product Overview
10.1.3 Advpharma Inc Lung Cancer Diagnostic Tests Product Market Performance
10.1.4 Advpharma Inc Business Overview
10.1.5 Advpharma Inc SWOT Analysis
10.1.6 Advpharma Inc Recent Developments
10.2 AIT Austrian Institute of Technology GmbH
10.2.1 AIT Austrian Institute of Technology GmbH Basic Information
10.2.2 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Product Overview
10.2.3 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Product Market Performance
10.2.4 AIT Austrian Institute of Technology GmbH Business Overview
10.2.5 AIT Austrian Institute of Technology GmbH SWOT Analysis
10.2.6 AIT Austrian Institute of Technology GmbH Recent Developments
10.3 Courtagen Life Sciences Inc
10.3.1 Courtagen Life Sciences Inc Basic Information
10.3.2 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Product Overview
10.3.3 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Product Market Performance
10.3.4 Courtagen Life Sciences Inc Business Overview
10.3.5 Courtagen Life Sciences Inc SWOT Analysis
10.3.6 Courtagen Life Sciences Inc Recent Developments
10.4 DiagnoCure Inc. (Inactive)
10.4.1 DiagnoCure Inc. (Inactive) Basic Information
10.4.2 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Product Overview
10.4.3 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Product Market Performance
10.4.4 DiagnoCure Inc. (Inactive) Business Overview
10.4.5 DiagnoCure Inc. (Inactive) Recent Developments
10.5 BioMark Diagnostics Inc.
10.5.1 BioMark Diagnostics Inc. Basic Information
10.5.2 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Product Overview
10.5.3 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Product Market Performance
10.5.4 BioMark Diagnostics Inc. Business Overview
10.5.5 BioMark Diagnostics Inc. Recent Developments
10.6 BioMarker Strategies LLC
10.6.1 BioMarker Strategies LLC Basic Information
10.6.2 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Product Overview
10.6.3 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Product Market Performance
10.6.4 BioMarker Strategies LLC Business Overview
10.6.5 BioMarker Strategies LLC Recent Developments
10.7 Emory University
10.7.1 Emory University Basic Information
10.7.2 Emory University Lung Cancer Diagnostic Tests Product Overview
10.7.3 Emory University Lung Cancer Diagnostic Tests Product Market Performance
10.7.4 Emory University Business Overview
10.7.5 Emory University Recent Developments
10.8 Epigenomics AG
10.8.1 Epigenomics AG Basic Information
10.8.2 Epigenomics AG Lung Cancer Diagnostic Tests Product Overview
10.8.3 Epigenomics AG Lung Cancer Diagnostic Tests Product Market Performance
10.8.4 Epigenomics AG Business Overview
10.8.5 Epigenomics AG Recent Developments
10.9 GlycoZym
10.9.1 GlycoZym Basic Information
10.9.2 GlycoZym Lung Cancer Diagnostic Tests Product Overview
10.9.3 GlycoZym Lung Cancer Diagnostic Tests Product Market Performance
10.9.4 GlycoZym Business Overview
10.9.5 GlycoZym Recent Developments
10.10 HalioDx SAS
10.10.1 HalioDx SAS Basic Information
10.10.2 HalioDx SAS Lung Cancer Diagnostic Tests Product Overview
10.10.3 HalioDx SAS Lung Cancer Diagnostic Tests Product Market Performance
10.10.4 HalioDx SAS Business Overview
10.10.5 HalioDx SAS Recent Developments
10.11 Louisville BioscienceInc.
10.11.1 Louisville BioscienceInc. Basic Information
10.11.2 Louisville BioscienceInc. Lung Cancer Diagnostic Tests Product Overview
10.11.3 Louisville BioscienceInc. Lung Cancer Diagnostic Tests Product Market Performance
10.11.4 Louisville BioscienceInc. Business Overview
10.11.5 Louisville BioscienceInc. Recent Developments
10.12 Mayo Clinic US
10.12.1 Mayo Clinic US Basic Information
10.12.2 Mayo Clinic US Lung Cancer Diagnostic Tests Product Overview
10.12.3 Mayo Clinic US Lung Cancer Diagnostic Tests Product Market Performance
10.12.4 Mayo Clinic US Business Overview
10.12.5 Mayo Clinic US Recent Developments
11 LUNG CANCER DIAGNOSTIC TESTS MARKET FORECAST BY REGION
11.1 Global Lung Cancer Diagnostic Tests Market Size Forecast
11.2 Global Lung Cancer Diagnostic Tests Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Lung Cancer Diagnostic Tests Market Size Forecast by Country
11.2.3 Asia Pacific Lung Cancer Diagnostic Tests Market Size Forecast by Region
11.2.4 South America Lung Cancer Diagnostic Tests Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Lung Cancer Diagnostic Tests by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Lung Cancer Diagnostic Tests Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Lung Cancer Diagnostic Tests by Type (2026-2033)
12.1.2 Global Lung Cancer Diagnostic Tests Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Lung Cancer Diagnostic Tests by Type (2026-2033)
12.2 Global Lung Cancer Diagnostic Tests Market Forecast by Application (2026-2033)
12.2.1 Global Lung Cancer Diagnostic Tests Sales (K Units) Forecast by Application
12.2.2 Global Lung Cancer Diagnostic Tests Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Lung Cancer Diagnostic Tests
1.2 Key Market Segments
1.2.1 Lung Cancer Diagnostic Tests Segment by Type
1.2.2 Lung Cancer Diagnostic Tests Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LUNG CANCER DIAGNOSTIC TESTS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Lung Cancer Diagnostic Tests Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Lung Cancer Diagnostic Tests Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LUNG CANCER DIAGNOSTIC TESTS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Lung Cancer Diagnostic Tests Product Life Cycle
3.3 Global Lung Cancer Diagnostic Tests Sales by Manufacturers (2020-2025)
3.4 Global Lung Cancer Diagnostic Tests Revenue Market Share by Manufacturers (2020-2025)
3.5 Lung Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Lung Cancer Diagnostic Tests Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Lung Cancer Diagnostic Tests Market Competitive Situation and Trends
3.8.1 Lung Cancer Diagnostic Tests Market Concentration Rate
3.8.2 Global 5 and 10 Largest Lung Cancer Diagnostic Tests Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 LUNG CANCER DIAGNOSTIC TESTS INDUSTRY CHAIN ANALYSIS
4.1 Lung Cancer Diagnostic Tests Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LUNG CANCER DIAGNOSTIC TESTS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Lung Cancer Diagnostic Tests Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Lung Cancer Diagnostic Tests Market
5.7 ESG Ratings of Leading Companies
6 LUNG CANCER DIAGNOSTIC TESTS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Lung Cancer Diagnostic Tests Sales Market Share by Type (2020-2025)
6.3 Global Lung Cancer Diagnostic Tests Market Size Market Share by Type (2020-2025)
6.4 Global Lung Cancer Diagnostic Tests Price by Type (2020-2025)
7 LUNG CANCER DIAGNOSTIC TESTS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Lung Cancer Diagnostic Tests Market Sales by Application (2020-2025)
7.3 Global Lung Cancer Diagnostic Tests Market Size (M USD) by Application (2020-2025)
7.4 Global Lung Cancer Diagnostic Tests Sales Growth Rate by Application (2020-2025)
8 LUNG CANCER DIAGNOSTIC TESTS MARKET SALES BY REGION
8.1 Global Lung Cancer Diagnostic Tests Sales by Region
8.1.1 Global Lung Cancer Diagnostic Tests Sales by Region
8.1.2 Global Lung Cancer Diagnostic Tests Sales Market Share by Region
8.2 Global Lung Cancer Diagnostic Tests Market Size by Region
8.2.1 Global Lung Cancer Diagnostic Tests Market Size by Region
8.2.2 Global Lung Cancer Diagnostic Tests Market Size Market Share by Region
8.3 North America
8.3.1 North America Lung Cancer Diagnostic Tests Sales by Country
8.3.2 North America Lung Cancer Diagnostic Tests Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Lung Cancer Diagnostic Tests Sales by Country
8.4.2 Europe Lung Cancer Diagnostic Tests Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Lung Cancer Diagnostic Tests Sales by Region
8.5.2 Asia Pacific Lung Cancer Diagnostic Tests Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Lung Cancer Diagnostic Tests Sales by Country
8.6.2 South America Lung Cancer Diagnostic Tests Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Lung Cancer Diagnostic Tests Sales by Region
8.7.2 Middle East and Africa Lung Cancer Diagnostic Tests Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 LUNG CANCER DIAGNOSTIC TESTS MARKET PRODUCTION BY REGION
9.1 Global Production of Lung Cancer Diagnostic Tests by Region(2020-2025)
9.2 Global Lung Cancer Diagnostic Tests Revenue Market Share by Region (2020-2025)
9.3 Global Lung Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Lung Cancer Diagnostic Tests Production
9.4.1 North America Lung Cancer Diagnostic Tests Production Growth Rate (2020-2025)
9.4.2 North America Lung Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Lung Cancer Diagnostic Tests Production
9.5.1 Europe Lung Cancer Diagnostic Tests Production Growth Rate (2020-2025)
9.5.2 Europe Lung Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Lung Cancer Diagnostic Tests Production (2020-2025)
9.6.1 Japan Lung Cancer Diagnostic Tests Production Growth Rate (2020-2025)
9.6.2 Japan Lung Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Lung Cancer Diagnostic Tests Production (2020-2025)
9.7.1 China Lung Cancer Diagnostic Tests Production Growth Rate (2020-2025)
9.7.2 China Lung Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Advpharma Inc
10.1.1 Advpharma Inc Basic Information
10.1.2 Advpharma Inc Lung Cancer Diagnostic Tests Product Overview
10.1.3 Advpharma Inc Lung Cancer Diagnostic Tests Product Market Performance
10.1.4 Advpharma Inc Business Overview
10.1.5 Advpharma Inc SWOT Analysis
10.1.6 Advpharma Inc Recent Developments
10.2 AIT Austrian Institute of Technology GmbH
10.2.1 AIT Austrian Institute of Technology GmbH Basic Information
10.2.2 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Product Overview
10.2.3 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Product Market Performance
10.2.4 AIT Austrian Institute of Technology GmbH Business Overview
10.2.5 AIT Austrian Institute of Technology GmbH SWOT Analysis
10.2.6 AIT Austrian Institute of Technology GmbH Recent Developments
10.3 Courtagen Life Sciences Inc
10.3.1 Courtagen Life Sciences Inc Basic Information
10.3.2 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Product Overview
10.3.3 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Product Market Performance
10.3.4 Courtagen Life Sciences Inc Business Overview
10.3.5 Courtagen Life Sciences Inc SWOT Analysis
10.3.6 Courtagen Life Sciences Inc Recent Developments
10.4 DiagnoCure Inc. (Inactive)
10.4.1 DiagnoCure Inc. (Inactive) Basic Information
10.4.2 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Product Overview
10.4.3 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Product Market Performance
10.4.4 DiagnoCure Inc. (Inactive) Business Overview
10.4.5 DiagnoCure Inc. (Inactive) Recent Developments
10.5 BioMark Diagnostics Inc.
10.5.1 BioMark Diagnostics Inc. Basic Information
10.5.2 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Product Overview
10.5.3 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Product Market Performance
10.5.4 BioMark Diagnostics Inc. Business Overview
10.5.5 BioMark Diagnostics Inc. Recent Developments
10.6 BioMarker Strategies LLC
10.6.1 BioMarker Strategies LLC Basic Information
10.6.2 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Product Overview
10.6.3 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Product Market Performance
10.6.4 BioMarker Strategies LLC Business Overview
10.6.5 BioMarker Strategies LLC Recent Developments
10.7 Emory University
10.7.1 Emory University Basic Information
10.7.2 Emory University Lung Cancer Diagnostic Tests Product Overview
10.7.3 Emory University Lung Cancer Diagnostic Tests Product Market Performance
10.7.4 Emory University Business Overview
10.7.5 Emory University Recent Developments
10.8 Epigenomics AG
10.8.1 Epigenomics AG Basic Information
10.8.2 Epigenomics AG Lung Cancer Diagnostic Tests Product Overview
10.8.3 Epigenomics AG Lung Cancer Diagnostic Tests Product Market Performance
10.8.4 Epigenomics AG Business Overview
10.8.5 Epigenomics AG Recent Developments
10.9 GlycoZym
10.9.1 GlycoZym Basic Information
10.9.2 GlycoZym Lung Cancer Diagnostic Tests Product Overview
10.9.3 GlycoZym Lung Cancer Diagnostic Tests Product Market Performance
10.9.4 GlycoZym Business Overview
10.9.5 GlycoZym Recent Developments
10.10 HalioDx SAS
10.10.1 HalioDx SAS Basic Information
10.10.2 HalioDx SAS Lung Cancer Diagnostic Tests Product Overview
10.10.3 HalioDx SAS Lung Cancer Diagnostic Tests Product Market Performance
10.10.4 HalioDx SAS Business Overview
10.10.5 HalioDx SAS Recent Developments
10.11 Louisville BioscienceInc.
10.11.1 Louisville BioscienceInc. Basic Information
10.11.2 Louisville BioscienceInc. Lung Cancer Diagnostic Tests Product Overview
10.11.3 Louisville BioscienceInc. Lung Cancer Diagnostic Tests Product Market Performance
10.11.4 Louisville BioscienceInc. Business Overview
10.11.5 Louisville BioscienceInc. Recent Developments
10.12 Mayo Clinic US
10.12.1 Mayo Clinic US Basic Information
10.12.2 Mayo Clinic US Lung Cancer Diagnostic Tests Product Overview
10.12.3 Mayo Clinic US Lung Cancer Diagnostic Tests Product Market Performance
10.12.4 Mayo Clinic US Business Overview
10.12.5 Mayo Clinic US Recent Developments
11 LUNG CANCER DIAGNOSTIC TESTS MARKET FORECAST BY REGION
11.1 Global Lung Cancer Diagnostic Tests Market Size Forecast
11.2 Global Lung Cancer Diagnostic Tests Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Lung Cancer Diagnostic Tests Market Size Forecast by Country
11.2.3 Asia Pacific Lung Cancer Diagnostic Tests Market Size Forecast by Region
11.2.4 South America Lung Cancer Diagnostic Tests Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Lung Cancer Diagnostic Tests by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Lung Cancer Diagnostic Tests Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Lung Cancer Diagnostic Tests by Type (2026-2033)
12.1.2 Global Lung Cancer Diagnostic Tests Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Lung Cancer Diagnostic Tests by Type (2026-2033)
12.2 Global Lung Cancer Diagnostic Tests Market Forecast by Application (2026-2033)
12.2.1 Global Lung Cancer Diagnostic Tests Sales (K Units) Forecast by Application
12.2.2 Global Lung Cancer Diagnostic Tests Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Lung Cancer Diagnostic Tests Market Size Comparison by Region (M USD)
Table 5. Global Lung Cancer Diagnostic Tests Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Lung Cancer Diagnostic Tests Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Lung Cancer Diagnostic Tests Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Lung Cancer Diagnostic Tests Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Diagnostic Tests as of 2024)
Table 10. Global Market Lung Cancer Diagnostic Tests Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Lung Cancer Diagnostic Tests Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Lung Cancer Diagnostic Tests Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Lung Cancer Diagnostic Tests Sales by Type (K Units)
Table 26. Global Lung Cancer Diagnostic Tests Market Size by Type (M USD)
Table 27. Global Lung Cancer Diagnostic Tests Sales (K Units) by Type (2020-2025)
Table 28. Global Lung Cancer Diagnostic Tests Sales Market Share by Type (2020-2025)
Table 29. Global Lung Cancer Diagnostic Tests Market Size (M USD) by Type (2020-2025)
Table 30. Global Lung Cancer Diagnostic Tests Market Size Share by Type (2020-2025)
Table 31. Global Lung Cancer Diagnostic Tests Price (USD/Unit) by Type (2020-2025)
Table 32. Global Lung Cancer Diagnostic Tests Sales (K Units) by Application
Table 33. Global Lung Cancer Diagnostic Tests Market Size by Application
Table 34. Global Lung Cancer Diagnostic Tests Sales by Application (2020-2025) & (K Units)
Table 35. Global Lung Cancer Diagnostic Tests Sales Market Share by Application (2020-2025)
Table 36. Global Lung Cancer Diagnostic Tests Market Size by Application (2020-2025) & (M USD)
Table 37. Global Lung Cancer Diagnostic Tests Market Share by Application (2020-2025)
Table 38. Global Lung Cancer Diagnostic Tests Sales Growth Rate by Application (2020-2025)
Table 39. Global Lung Cancer Diagnostic Tests Sales by Region (2020-2025) & (K Units)
Table 40. Global Lung Cancer Diagnostic Tests Sales Market Share by Region (2020-2025)
Table 41. Global Lung Cancer Diagnostic Tests Market Size by Region (2020-2025) & (M USD)
Table 42. Global Lung Cancer Diagnostic Tests Market Size Market Share by Region (2020-2025)
Table 43. North America Lung Cancer Diagnostic Tests Sales by Country (2020-2025) & (K Units)
Table 44. North America Lung Cancer Diagnostic Tests Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Lung Cancer Diagnostic Tests Sales by Country (2020-2025) & (K Units)
Table 46. Europe Lung Cancer Diagnostic Tests Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Lung Cancer Diagnostic Tests Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Lung Cancer Diagnostic Tests Market Size by Region (2020-2025) & (M USD)
Table 49. South America Lung Cancer Diagnostic Tests Sales by Country (2020-2025) & (K Units)
Table 50. South America Lung Cancer Diagnostic Tests Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Lung Cancer Diagnostic Tests Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Lung Cancer Diagnostic Tests Market Size by Region (2020-2025) & (M USD)
Table 53. Global Lung Cancer Diagnostic Tests Production (K Units) by Region(2020-2025)
Table 54. Global Lung Cancer Diagnostic Tests Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Lung Cancer Diagnostic Tests Revenue Market Share by Region (2020-2025)
Table 56. Global Lung Cancer Diagnostic Tests Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Lung Cancer Diagnostic Tests Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Lung Cancer Diagnostic Tests Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Lung Cancer Diagnostic Tests Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Lung Cancer Diagnostic Tests Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Advpharma Inc Basic Information
Table 62. Advpharma Inc Lung Cancer Diagnostic Tests Product Overview
Table 63. Advpharma Inc Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Advpharma Inc Business Overview
Table 65. Advpharma Inc SWOT Analysis
Table 66. Advpharma Inc Recent Developments
Table 67. AIT Austrian Institute of Technology GmbH Basic Information
Table 68. AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Product Overview
Table 69. AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. AIT Austrian Institute of Technology GmbH Business Overview
Table 71. AIT Austrian Institute of Technology GmbH SWOT Analysis
Table 72. AIT Austrian Institute of Technology GmbH Recent Developments
Table 73. Courtagen Life Sciences Inc Basic Information
Table 74. Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Product Overview
Table 75. Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Courtagen Life Sciences Inc Business Overview
Table 77. Courtagen Life Sciences Inc SWOT Analysis
Table 78. Courtagen Life Sciences Inc Recent Developments
Table 79. DiagnoCure Inc. (Inactive) Basic Information
Table 80. DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Product Overview
Table 81. DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. DiagnoCure Inc. (Inactive) Business Overview
Table 83. DiagnoCure Inc. (Inactive) Recent Developments
Table 84. BioMark Diagnostics Inc. Basic Information
Table 85. BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Product Overview
Table 86. BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. BioMark Diagnostics Inc. Business Overview
Table 88. BioMark Diagnostics Inc. Recent Developments
Table 89. BioMarker Strategies LLC Basic Information
Table 90. BioMarker Strategies LLC Lung Cancer Diagnostic Tests Product Overview
Table 91. BioMarker Strategies LLC Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. BioMarker Strategies LLC Business Overview
Table 93. BioMarker Strategies LLC Recent Developments
Table 94. Emory University Basic Information
Table 95. Emory University Lung Cancer Diagnostic Tests Product Overview
Table 96. Emory University Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Emory University Business Overview
Table 98. Emory University Recent Developments
Table 99. Epigenomics AG Basic Information
Table 100. Epigenomics AG Lung Cancer Diagnostic Tests Product Overview
Table 101. Epigenomics AG Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Epigenomics AG Business Overview
Table 103. Epigenomics AG Recent Developments
Table 104. GlycoZym Basic Information
Table 105. GlycoZym Lung Cancer Diagnostic Tests Product Overview
Table 106. GlycoZym Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. GlycoZym Business Overview
Table 108. GlycoZym Recent Developments
Table 109. HalioDx SAS Basic Information
Table 110. HalioDx SAS Lung Cancer Diagnostic Tests Product Overview
Table 111. HalioDx SAS Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. HalioDx SAS Business Overview
Table 113. HalioDx SAS Recent Developments
Table 114. Louisville BioscienceInc. Basic Information
Table 115. Louisville BioscienceInc. Lung Cancer Diagnostic Tests Product Overview
Table 116. Louisville BioscienceInc. Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Louisville BioscienceInc. Business Overview
Table 118. Louisville BioscienceInc. Recent Developments
Table 119. Mayo Clinic US Basic Information
Table 120. Mayo Clinic US Lung Cancer Diagnostic Tests Product Overview
Table 121. Mayo Clinic US Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Mayo Clinic US Business Overview
Table 123. Mayo Clinic US Recent Developments
Table 124. Global Lung Cancer Diagnostic Tests Sales Forecast by Region (2026-2033) & (K Units)
Table 125. Global Lung Cancer Diagnostic Tests Market Size Forecast by Region (2026-2033) & (M USD)
Table 126. North America Lung Cancer Diagnostic Tests Sales Forecast by Country (2026-2033) & (K Units)
Table 127. North America Lung Cancer Diagnostic Tests Market Size Forecast by Country (2026-2033) & (M USD)
Table 128. Europe Lung Cancer Diagnostic Tests Sales Forecast by Country (2026-2033) & (K Units)
Table 129. Europe Lung Cancer Diagnostic Tests Market Size Forecast by Country (2026-2033) & (M USD)
Table 130. Asia Pacific Lung Cancer Diagnostic Tests Sales Forecast by Region (2026-2033) & (K Units)
Table 131. Asia Pacific Lung Cancer Diagnostic Tests Market Size Forecast by Region (2026-2033) & (M USD)
Table 132. South America Lung Cancer Diagnostic Tests Sales Forecast by Country (2026-2033) & (K Units)
Table 133. South America Lung Cancer Diagnostic Tests Market Size Forecast by Country (2026-2033) & (M USD)
Table 134. Middle East and Africa Lung Cancer Diagnostic Tests Sales Forecast by Country (2026-2033) & (Units)
Table 135. Middle East and Africa Lung Cancer Diagnostic Tests Market Size Forecast by Country (2026-2033) & (M USD)
Table 136. Global Lung Cancer Diagnostic Tests Sales Forecast by Type (2026-2033) & (K Units)
Table 137. Global Lung Cancer Diagnostic Tests Market Size Forecast by Type (2026-2033) & (M USD)
Table 138. Global Lung Cancer Diagnostic Tests Price Forecast by Type (2026-2033) & (USD/Unit)
Table 139. Global Lung Cancer Diagnostic Tests Sales (K Units) Forecast by Application (2026-2033)
Table 140. Global Lung Cancer Diagnostic Tests Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Lung Cancer Diagnostic Tests Market Size Comparison by Region (M USD)
Table 5. Global Lung Cancer Diagnostic Tests Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Lung Cancer Diagnostic Tests Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Lung Cancer Diagnostic Tests Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Lung Cancer Diagnostic Tests Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Diagnostic Tests as of 2024)
Table 10. Global Market Lung Cancer Diagnostic Tests Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Lung Cancer Diagnostic Tests Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Lung Cancer Diagnostic Tests Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Lung Cancer Diagnostic Tests Sales by Type (K Units)
Table 26. Global Lung Cancer Diagnostic Tests Market Size by Type (M USD)
Table 27. Global Lung Cancer Diagnostic Tests Sales (K Units) by Type (2020-2025)
Table 28. Global Lung Cancer Diagnostic Tests Sales Market Share by Type (2020-2025)
Table 29. Global Lung Cancer Diagnostic Tests Market Size (M USD) by Type (2020-2025)
Table 30. Global Lung Cancer Diagnostic Tests Market Size Share by Type (2020-2025)
Table 31. Global Lung Cancer Diagnostic Tests Price (USD/Unit) by Type (2020-2025)
Table 32. Global Lung Cancer Diagnostic Tests Sales (K Units) by Application
Table 33. Global Lung Cancer Diagnostic Tests Market Size by Application
Table 34. Global Lung Cancer Diagnostic Tests Sales by Application (2020-2025) & (K Units)
Table 35. Global Lung Cancer Diagnostic Tests Sales Market Share by Application (2020-2025)
Table 36. Global Lung Cancer Diagnostic Tests Market Size by Application (2020-2025) & (M USD)
Table 37. Global Lung Cancer Diagnostic Tests Market Share by Application (2020-2025)
Table 38. Global Lung Cancer Diagnostic Tests Sales Growth Rate by Application (2020-2025)
Table 39. Global Lung Cancer Diagnostic Tests Sales by Region (2020-2025) & (K Units)
Table 40. Global Lung Cancer Diagnostic Tests Sales Market Share by Region (2020-2025)
Table 41. Global Lung Cancer Diagnostic Tests Market Size by Region (2020-2025) & (M USD)
Table 42. Global Lung Cancer Diagnostic Tests Market Size Market Share by Region (2020-2025)
Table 43. North America Lung Cancer Diagnostic Tests Sales by Country (2020-2025) & (K Units)
Table 44. North America Lung Cancer Diagnostic Tests Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Lung Cancer Diagnostic Tests Sales by Country (2020-2025) & (K Units)
Table 46. Europe Lung Cancer Diagnostic Tests Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Lung Cancer Diagnostic Tests Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Lung Cancer Diagnostic Tests Market Size by Region (2020-2025) & (M USD)
Table 49. South America Lung Cancer Diagnostic Tests Sales by Country (2020-2025) & (K Units)
Table 50. South America Lung Cancer Diagnostic Tests Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Lung Cancer Diagnostic Tests Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Lung Cancer Diagnostic Tests Market Size by Region (2020-2025) & (M USD)
Table 53. Global Lung Cancer Diagnostic Tests Production (K Units) by Region(2020-2025)
Table 54. Global Lung Cancer Diagnostic Tests Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Lung Cancer Diagnostic Tests Revenue Market Share by Region (2020-2025)
Table 56. Global Lung Cancer Diagnostic Tests Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Lung Cancer Diagnostic Tests Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Lung Cancer Diagnostic Tests Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Lung Cancer Diagnostic Tests Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Lung Cancer Diagnostic Tests Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Advpharma Inc Basic Information
Table 62. Advpharma Inc Lung Cancer Diagnostic Tests Product Overview
Table 63. Advpharma Inc Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Advpharma Inc Business Overview
Table 65. Advpharma Inc SWOT Analysis
Table 66. Advpharma Inc Recent Developments
Table 67. AIT Austrian Institute of Technology GmbH Basic Information
Table 68. AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Product Overview
Table 69. AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. AIT Austrian Institute of Technology GmbH Business Overview
Table 71. AIT Austrian Institute of Technology GmbH SWOT Analysis
Table 72. AIT Austrian Institute of Technology GmbH Recent Developments
Table 73. Courtagen Life Sciences Inc Basic Information
Table 74. Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Product Overview
Table 75. Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Courtagen Life Sciences Inc Business Overview
Table 77. Courtagen Life Sciences Inc SWOT Analysis
Table 78. Courtagen Life Sciences Inc Recent Developments
Table 79. DiagnoCure Inc. (Inactive) Basic Information
Table 80. DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Product Overview
Table 81. DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. DiagnoCure Inc. (Inactive) Business Overview
Table 83. DiagnoCure Inc. (Inactive) Recent Developments
Table 84. BioMark Diagnostics Inc. Basic Information
Table 85. BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Product Overview
Table 86. BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. BioMark Diagnostics Inc. Business Overview
Table 88. BioMark Diagnostics Inc. Recent Developments
Table 89. BioMarker Strategies LLC Basic Information
Table 90. BioMarker Strategies LLC Lung Cancer Diagnostic Tests Product Overview
Table 91. BioMarker Strategies LLC Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. BioMarker Strategies LLC Business Overview
Table 93. BioMarker Strategies LLC Recent Developments
Table 94. Emory University Basic Information
Table 95. Emory University Lung Cancer Diagnostic Tests Product Overview
Table 96. Emory University Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Emory University Business Overview
Table 98. Emory University Recent Developments
Table 99. Epigenomics AG Basic Information
Table 100. Epigenomics AG Lung Cancer Diagnostic Tests Product Overview
Table 101. Epigenomics AG Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Epigenomics AG Business Overview
Table 103. Epigenomics AG Recent Developments
Table 104. GlycoZym Basic Information
Table 105. GlycoZym Lung Cancer Diagnostic Tests Product Overview
Table 106. GlycoZym Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. GlycoZym Business Overview
Table 108. GlycoZym Recent Developments
Table 109. HalioDx SAS Basic Information
Table 110. HalioDx SAS Lung Cancer Diagnostic Tests Product Overview
Table 111. HalioDx SAS Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. HalioDx SAS Business Overview
Table 113. HalioDx SAS Recent Developments
Table 114. Louisville BioscienceInc. Basic Information
Table 115. Louisville BioscienceInc. Lung Cancer Diagnostic Tests Product Overview
Table 116. Louisville BioscienceInc. Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Louisville BioscienceInc. Business Overview
Table 118. Louisville BioscienceInc. Recent Developments
Table 119. Mayo Clinic US Basic Information
Table 120. Mayo Clinic US Lung Cancer Diagnostic Tests Product Overview
Table 121. Mayo Clinic US Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Mayo Clinic US Business Overview
Table 123. Mayo Clinic US Recent Developments
Table 124. Global Lung Cancer Diagnostic Tests Sales Forecast by Region (2026-2033) & (K Units)
Table 125. Global Lung Cancer Diagnostic Tests Market Size Forecast by Region (2026-2033) & (M USD)
Table 126. North America Lung Cancer Diagnostic Tests Sales Forecast by Country (2026-2033) & (K Units)
Table 127. North America Lung Cancer Diagnostic Tests Market Size Forecast by Country (2026-2033) & (M USD)
Table 128. Europe Lung Cancer Diagnostic Tests Sales Forecast by Country (2026-2033) & (K Units)
Table 129. Europe Lung Cancer Diagnostic Tests Market Size Forecast by Country (2026-2033) & (M USD)
Table 130. Asia Pacific Lung Cancer Diagnostic Tests Sales Forecast by Region (2026-2033) & (K Units)
Table 131. Asia Pacific Lung Cancer Diagnostic Tests Market Size Forecast by Region (2026-2033) & (M USD)
Table 132. South America Lung Cancer Diagnostic Tests Sales Forecast by Country (2026-2033) & (K Units)
Table 133. South America Lung Cancer Diagnostic Tests Market Size Forecast by Country (2026-2033) & (M USD)
Table 134. Middle East and Africa Lung Cancer Diagnostic Tests Sales Forecast by Country (2026-2033) & (Units)
Table 135. Middle East and Africa Lung Cancer Diagnostic Tests Market Size Forecast by Country (2026-2033) & (M USD)
Table 136. Global Lung Cancer Diagnostic Tests Sales Forecast by Type (2026-2033) & (K Units)
Table 137. Global Lung Cancer Diagnostic Tests Market Size Forecast by Type (2026-2033) & (M USD)
Table 138. Global Lung Cancer Diagnostic Tests Price Forecast by Type (2026-2033) & (USD/Unit)
Table 139. Global Lung Cancer Diagnostic Tests Sales (K Units) Forecast by Application (2026-2033)
Table 140. Global Lung Cancer Diagnostic Tests Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Lung Cancer Diagnostic Tests
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Lung Cancer Diagnostic Tests Market Size (M USD), 2024-2033
Figure 5. Global Lung Cancer Diagnostic Tests Market Size (M USD) (2020-2033)
Figure 6. Global Lung Cancer Diagnostic Tests Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Lung Cancer Diagnostic Tests Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Lung Cancer Diagnostic Tests Product Life Cycle
Figure 13. Lung Cancer Diagnostic Tests Sales Share by Manufacturers in 2024
Figure 14. Global Lung Cancer Diagnostic Tests Revenue Share by Manufacturers in 2024
Figure 15. Lung Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Lung Cancer Diagnostic Tests Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Lung Cancer Diagnostic Tests Revenue in 2024
Figure 18. Industry Chain Map of Lung Cancer Diagnostic Tests
Figure 19. Global Lung Cancer Diagnostic Tests Market PEST Analysis
Figure 20. Global Lung Cancer Diagnostic Tests Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Lung Cancer Diagnostic Tests Market Share by Type
Figure 27. Sales Market Share of Lung Cancer Diagnostic Tests by Type (2020-2025)
Figure 28. Sales Market Share of Lung Cancer Diagnostic Tests by Type in 2024
Figure 29. Market Size Share of Lung Cancer Diagnostic Tests by Type (2020-2025)
Figure 30. Market Size Share of Lung Cancer Diagnostic Tests by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Lung Cancer Diagnostic Tests Market Share by Application
Figure 33. Global Lung Cancer Diagnostic Tests Sales Market Share by Application (2020-2025)
Figure 34. Global Lung Cancer Diagnostic Tests Sales Market Share by Application in 2024
Figure 35. Global Lung Cancer Diagnostic Tests Market Share by Application (2020-2025)
Figure 36. Global Lung Cancer Diagnostic Tests Market Share by Application in 2024
Figure 37. Global Lung Cancer Diagnostic Tests Sales Growth Rate by Application (2020-2025)
Figure 38. Global Lung Cancer Diagnostic Tests Sales Market Share by Region (2020-2025)
Figure 39. Global Lung Cancer Diagnostic Tests Market Size Market Share by Region (2020-2025)
Figure 40. North America Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Lung Cancer Diagnostic Tests Sales Market Share by Country in 2024
Figure 43. North America Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Lung Cancer Diagnostic Tests Market Size Market Share by Country in 2024
Figure 45. U.S. Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Lung Cancer Diagnostic Tests Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Lung Cancer Diagnostic Tests Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Lung Cancer Diagnostic Tests Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Lung Cancer Diagnostic Tests Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Lung Cancer Diagnostic Tests Sales Market Share by Country in 2024
Figure 53. Europe Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Lung Cancer Diagnostic Tests Market Size Market Share by Country in 2024
Figure 55. Germany Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Lung Cancer Diagnostic Tests Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Lung Cancer Diagnostic Tests Sales Market Share by Region in 2024
Figure 67. Asia Pacific Lung Cancer Diagnostic Tests Market Size Market Share by Region in 2024
Figure 68. China Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Lung Cancer Diagnostic Tests Sales and Growth Rate (K Units)
Figure 79. South America Lung Cancer Diagnostic Tests Sales Market Share by Country in 2024
Figure 80. South America Lung Cancer Diagnostic Tests Market Size and Growth Rate (M USD)
Figure 81. South America Lung Cancer Diagnostic Tests Market Size Market Share by Country in 2024
Figure 82. Brazil Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Lung Cancer Diagnostic Tests Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Lung Cancer Diagnostic Tests Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Lung Cancer Diagnostic Tests Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Lung Cancer Diagnostic Tests Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Lung Cancer Diagnostic Tests Production Market Share by Region (2020-2025)
Figure 103. North America Lung Cancer Diagnostic Tests Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Lung Cancer Diagnostic Tests Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Lung Cancer Diagnostic Tests Production (K Units) Growth Rate (2020-2025)
Figure 106. China Lung Cancer Diagnostic Tests Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Lung Cancer Diagnostic Tests Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Lung Cancer Diagnostic Tests Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Lung Cancer Diagnostic Tests Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Lung Cancer Diagnostic Tests Market Share Forecast by Type (2026-2033)
Figure 111. Global Lung Cancer Diagnostic Tests Sales Forecast by Application (2026-2033)
Figure 112. Global Lung Cancer Diagnostic Tests Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Lung Cancer Diagnostic Tests
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Lung Cancer Diagnostic Tests Market Size (M USD), 2024-2033
Figure 5. Global Lung Cancer Diagnostic Tests Market Size (M USD) (2020-2033)
Figure 6. Global Lung Cancer Diagnostic Tests Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Lung Cancer Diagnostic Tests Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Lung Cancer Diagnostic Tests Product Life Cycle
Figure 13. Lung Cancer Diagnostic Tests Sales Share by Manufacturers in 2024
Figure 14. Global Lung Cancer Diagnostic Tests Revenue Share by Manufacturers in 2024
Figure 15. Lung Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Lung Cancer Diagnostic Tests Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Lung Cancer Diagnostic Tests Revenue in 2024
Figure 18. Industry Chain Map of Lung Cancer Diagnostic Tests
Figure 19. Global Lung Cancer Diagnostic Tests Market PEST Analysis
Figure 20. Global Lung Cancer Diagnostic Tests Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Lung Cancer Diagnostic Tests Market Share by Type
Figure 27. Sales Market Share of Lung Cancer Diagnostic Tests by Type (2020-2025)
Figure 28. Sales Market Share of Lung Cancer Diagnostic Tests by Type in 2024
Figure 29. Market Size Share of Lung Cancer Diagnostic Tests by Type (2020-2025)
Figure 30. Market Size Share of Lung Cancer Diagnostic Tests by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Lung Cancer Diagnostic Tests Market Share by Application
Figure 33. Global Lung Cancer Diagnostic Tests Sales Market Share by Application (2020-2025)
Figure 34. Global Lung Cancer Diagnostic Tests Sales Market Share by Application in 2024
Figure 35. Global Lung Cancer Diagnostic Tests Market Share by Application (2020-2025)
Figure 36. Global Lung Cancer Diagnostic Tests Market Share by Application in 2024
Figure 37. Global Lung Cancer Diagnostic Tests Sales Growth Rate by Application (2020-2025)
Figure 38. Global Lung Cancer Diagnostic Tests Sales Market Share by Region (2020-2025)
Figure 39. Global Lung Cancer Diagnostic Tests Market Size Market Share by Region (2020-2025)
Figure 40. North America Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Lung Cancer Diagnostic Tests Sales Market Share by Country in 2024
Figure 43. North America Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Lung Cancer Diagnostic Tests Market Size Market Share by Country in 2024
Figure 45. U.S. Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Lung Cancer Diagnostic Tests Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Lung Cancer Diagnostic Tests Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Lung Cancer Diagnostic Tests Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Lung Cancer Diagnostic Tests Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Lung Cancer Diagnostic Tests Sales Market Share by Country in 2024
Figure 53. Europe Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Lung Cancer Diagnostic Tests Market Size Market Share by Country in 2024
Figure 55. Germany Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Lung Cancer Diagnostic Tests Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Lung Cancer Diagnostic Tests Sales Market Share by Region in 2024
Figure 67. Asia Pacific Lung Cancer Diagnostic Tests Market Size Market Share by Region in 2024
Figure 68. China Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Lung Cancer Diagnostic Tests Sales and Growth Rate (K Units)
Figure 79. South America Lung Cancer Diagnostic Tests Sales Market Share by Country in 2024
Figure 80. South America Lung Cancer Diagnostic Tests Market Size and Growth Rate (M USD)
Figure 81. South America Lung Cancer Diagnostic Tests Market Size Market Share by Country in 2024
Figure 82. Brazil Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Lung Cancer Diagnostic Tests Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Lung Cancer Diagnostic Tests Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Lung Cancer Diagnostic Tests Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Lung Cancer Diagnostic Tests Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Lung Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Lung Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Lung Cancer Diagnostic Tests Production Market Share by Region (2020-2025)
Figure 103. North America Lung Cancer Diagnostic Tests Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Lung Cancer Diagnostic Tests Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Lung Cancer Diagnostic Tests Production (K Units) Growth Rate (2020-2025)
Figure 106. China Lung Cancer Diagnostic Tests Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Lung Cancer Diagnostic Tests Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Lung Cancer Diagnostic Tests Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Lung Cancer Diagnostic Tests Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Lung Cancer Diagnostic Tests Market Share Forecast by Type (2026-2033)
Figure 111. Global Lung Cancer Diagnostic Tests Sales Forecast by Application (2026-2033)
Figure 112. Global Lung Cancer Diagnostic Tests Market Share Forecast by Application (2026-2033)
